At PRF, every donation is valued. PRF’s success would not have been possible without each and every one of our donors! Your support made 2018 a tremendous year of progress.

In 2018…

  • We learned that lonafarnib gives children with Progeria longer lives.
  • We partnered with Eiger BioPharmaceuticals to seek FDA approval for this life extending-drug.
  • Our clinical drug trial, through which the children receive lonafarnib, reached the half-way mark.
  • We held our 9th International Scientific Workshop which resulted in many new ideas and collaborations for the cure.

As we enter 2019, we thank you for helping us lead the way to curing Progeria.